XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.3
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 1,027 $ 1,293 $ 3,784 $ 4,033
Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.11  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.47   $ 3.47  
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 387 117 $ 1,298 311
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized Compensation Costs Related To Unvested Stock Options     940  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 636 523 $ 2,218 2,329
Restricted Stock Units (RSUs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     641,839  
Granted, nonvested, number of shares (in shares)     406,035  
Vested, number of shares (in shares)     (373,067)  
Forfeited, number of shares (in shares)     0  
Number of nonvested shares, end of period (in shares) 674,807   674,807  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 6.57  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     7.25  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     0  
Vested, weighted average grant date fair value (in dollars per share)     6.20  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 7.19   $ 7.19  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 4 $ 653 $ 268 $ 1,393
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,839,528  
Granted, nonvested, number of shares (in shares)     0  
Exercised, number of shares (in shares)     (250,036)  
Forfeited, number of shares (in shares)     (3,152)  
Expired (in shares)     (569,595)  
Number of nonvested shares, end of period (in shares) 1,016,745   1,016,745  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 5.01  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price     2.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     7.36  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair     2.94  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 6.67   $ 6.67  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number 0   0  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price $ 0   $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms     2 years 6 months 18 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 0   $ 0  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value $ 0   $ 0  
Stock Appreciation Rights (SARs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,589,492  
Granted, nonvested, number of shares (in shares)     0  
Vested, number of shares (in shares)     0  
Forfeited, number of shares (in shares)     (3,152)  
Expired (in shares)     (569,595)  
Number of nonvested shares, end of period (in shares) 1,016,745   1,016,745  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.89  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     3.45  
Vested, weighted average grant date fair value (in dollars per share)     0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair     1.22  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.83   $ 3.83